Abdul-Aziz, N. et al. (2023) “Multiple Sclerosis anti-CD20 (Ocrelizumab) therapy inducing hypogammaglobulinemia”, Translation: The University of Toledo Journal of Medical Sciences, 11(3). doi:10.46570/utjms.vol11-2023-836.